The active components of animal venoms are mostly peptide toxins, which typically target ion channels and receptors of both the central and peripheral nervous system, interfering with action potential conduction and/or synaptic transmission. The high degree of sequence conservation of their molecular targets makes a range of these toxins active at human receptors. The high selectivity and potency displayed by some of these toxins have prompted their use as pharmacological tools as well as drugs or drug leads. Molecular modelling has played an essential role in increasing our molecular-level understanding of the activity and specificity of animal toxins, as well as engineering them for biotechnological and pharmaceutical applications. This review focuses on the biological insights gained from computational and experimental studies of animal venom toxins interacting with membranes and ion channels. A host of recent X-ray crystallography and electron-microscopy structures of the toxin targets has contributed to a dramatic increase in the accuracy of the molecular models of toxin binding modes greatly advancing this exciting field of study.
on the nervous system (Kalia et al., 2015) . A number of peptides from this vast and complex pool of bioactive peptides have shown potential therapeutic applications, and the study of animal venoms attract considerable interest (Calvete, 2017; Kaas and Craik, 2015; Oldrati et al., 2016; Nasiripourdori et al., 2011) . Venoms of snakes, spiders, cone snails, scorpions, anemones, bees and wasps have been the most investigated, resulting in the identification of several thousands of toxins (Jungo et al., 2012) , but only a fraction of these toxins has been functionally characterised. For example, less than 200 out of the 2500 cone snail toxins currently identified have been pharmacologically characterised ; with the estimated total number of cone snail toxins being in the range of hundreds of thousand to millions (Akondi et al., 2014; Kaas and Craik, 2014) . Animal peptide toxins typically target large membrane proteins, making the structural characterisation of these interactions by nuclear magnetic resonance (NMR), X-ray crystallography or electron microscopy (EM) challenging. To date, only four experimental structures of a complex between a toxin and its molecular target have been determined, two are shown in Fig. 1 , and the other two are the scorpion charybdotoxin bound to the voltage-gated potassium channel K V 1.2 (Banerjee et al., 2013) and the spider toxin DkTx bound to the TRPV1 channel (Cao et al., 2013; Gao et al., 2016) . The snake a-bungarotoxin was crystallised in complex with the ligand-binding domain of an isolated nicotinic acetylcholine receptor (nAChR) a1 subunit (nAChR) (Dellisanti et al., 2007) as well as with an isolated ligand-binding domain of a human a9 nAChR subunit (Zouridakis et al., 2014) . The binding site in these crystal structures is largely incomplete because the binding site is located at the interface between two subunits. A number of experimental structures of complexes between toxin and structural homologues to the molecular target have also been determined, for example, the acetylcholine binding protein (AChBP), a structural surrogate for nAChRs, has been crystallised in complex with a range of toxins (Dutertre and Lewis, 2006) . Molecular modelling therefore plays an essential role in building hypotheses on toxin binding modes and mode of action, and in guiding the engineering of toxin activity. This review will focus on recent findings resulting from the molecular modelling of interactions between animal toxins and their membrane targets.
Some toxins, such as the bee melittin, directly target cellular membranes (Section 1), but the vast majority of peptide toxins act on ion channels in the nervous systems. The most common classes of ion channels targeted by animal toxins are the voltage-gated ion channels (Section 2) and the nicotinic acetylcholine receptors (nAChRs) (Section 3). The high degree of sequence conservation of these channels across animal phyla explains the potent activity of these toxins in humans (Jegla et al., 2009; Liebeskind et al., 2015 Liebeskind et al., , 2011 . Beyond voltage-gated ion channels and nAChRs, a diverse Fig. 1 . Examples of membrane proteins targeted by venom toxins: the G-protein coupled receptors (GPCRs), the voltage-gated calcium/sodium/potassium ion channels (Ca V / Na V /K V ), the nicotinic acetylcholine receptors (nAChR), the acid-sensing ion channels (ASIC) and the a-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid receptor (AMPAR). All these targets beside the GPCRs are ion channels. Representative toxins are shown in orange, and experimental structures of the targets are represented in blue colours. For each target, a view across the lipid membrane (pink) is at the top and a view from the extracellular side of the membrane is at the bottom. Red arrows indicate the flux of ions when the ion channels are open. The mamba snake toxin MT7 antagonises selectively the M1 muscarinic receptor, which is a GPCR. The crystal structure of the human M2 muscarinic receptor is here represented for illustration (Protein Data Bank PDB identifier: 4mqs) (Kruse et al., 2013) . The marine cone snail toxin MVIIA specifically blocks the pore of human Ca V 2.2. The electron microscopy structure of the rabbit Ca V 1.1 is here represented for illustration (PDB: 5gjv) . Most toxins targeting voltage-gated channels act by blocking the pore (arrow numbered 1 on the bottom) or by blocking the voltage sensor domains in various states (arrows 2). The cone snail toxin PeIA inhibits the a9a10 nAChR by competing with acetylcholine in the orthosteric sites, which are located between subunits in the ligand binding domain (indicated by arrows on the bottom). The nAChRs are pentamers and there is consequently a maximum of five binding sites. The crystal structure of the human a4b2 nAChR is here represented for illustration (PDB: 5kxi) (Morales-Perez et al., 2016) . The spider psalmotoxin-1, or PcTx1, binds at the interface between each subunit of ASIC 1a, stabilising the open state. The crystal structure of the complex between PcTx1 and chicken ASIC 1a is here represented (PDB: 4fz0) (Baconguis and Gouaux, 2012) . The cone snail toxin con-ikot-ikot blocks the desensitisation of AMPAR by binding as a dimer on top of the ligand-binding domain, plying open the pore of the channel (Chen et al., 2014) . (For interpretation of the references to colour in this figure legend, the reader is referred to the web version of this article.) range of membrane proteins in the nervous system is also targeted by toxins (Section 4), such as transporters and some G-proteincoupled receptors.
Toxins are typically selective toward a small subset of receptor subtypes, and the molecular modelling of toxin interactions typically begins with the prediction of the three-dimensional structure of the receptors using an experimentally-determined structure of a related protein. The recent expansion of our knowledge on the structures of some ion channel receptor subtypes has the potential to dramatically increase the accuracy of the predicted structures of toxin targets. The most significant examples are the crystal structure of the pentameric nAChRs (Morales-Perez et al., 2016) , the crystal structures of bacterial voltage-gated sodium channels (Payandeh et al., 2012 (Payandeh et al., , 2011 Zhang et al., 2012) , the EM structure of an insect voltage-gated sodium channel (Shen et al., 2017) and the EM structures of a mammalian voltage-gated calcium channel . Structural information on most of the toxin targets is nevertheless lacking because ion channels exist as a very large number of subtypes, which are linked to different functions and are expressed differentially in the nervous system (Catterall et al., 2005; Gotti et al., 2009) . Additionally, some toxins trap their target into a particular functional state (Cest ele et al., 2006; Stevens et al., 2011; Walker et al., 2009) , and it is therefore essential to model the toxin interaction with a certain receptor subtype in a precise activation state. The giant steps recently made in our understanding of the structural features linked to some of these states (Cecchini and Changeux, 2015; Clairfeuille et al., 2016; Plested, 2016; Sula et al., 2017) can be used in the modelling of the receptors as well as orient the docking. It should be noted that ion channels are complex systems, and a range of items are often overlooked in the molecular models, most notably protein glycosylation, the membrane lipid composition and the interactions with auxiliary proteins. As illustrated in Fig. 1 , the molecular surface of the membrane proteins is considerably larger than that of the toxins, and determining the toxin binding mode without any experimental data to orient the computational docking is difficult. Receptor residues potentially involved at the binding interface can be suggested from single point mutation studies (Leipold et al., 2005; Smith et al., 2007) , loop-swapping exercise (Bosmans et al., 2008) or by analysing sequence conservation among orthologous or paralogous sequences (Li-Smerin and Swartz, 1998) . Discovering a molecule competing with the toxin of interest and with a known binding mode is highly valuable (Corzo et al., 2003) . Ultimately, molecular interactions could also be suggested from doublemutant cycle analysis (Choudhary et al., 2007; Quiram et al., 2000; Yu et al., 2011) . Practically, docking is performed using rigid body docking or flexible docking and/or using molecular dynamics (MD) simulations. Several examples of docking simulations are described in Section 2. A model of the complex could also be built by homology using as template the structure of a complex between a related toxin and a related molecular target. This latter strategy is often employed for modelling toxins binding to the nAChR orthosteric binding site (Section 3). Beyond the qualitative description of the molecular interactions, some computational techniques can be used to predict the energetics of the interactions.
Venom peptides interacting with membranes
Although most peptide toxins exert their effect by interacting with a target protein only, some peptides act by forming a ternary complex with a membrane and receptor in concert or even target the membrane directly, leading to lysis of the cells. One of the most studied toxins of the latter class is melittin. Another well-known class of membrane active peptides are the snake venom cytotoxins, the activity of which has been reviewed recently (Gasanov et al., 2014) and will not be further discussed here.
Membrane-active toxins
Melittin is a 26 amino acid residue amphipathic peptide derived from the European honey bee Apis mellifera (Habermann, 1972 ). Melittin's membrane lytic activity (Tosteson and Tosteson, 1981) has been studied extensively using a variety of different techniques, including MD simulation, solid-state NMR spectroscopy, X-ray crystallography, fluorescence spectroscopy, electron microscopy, and CD spectroscopy (Bern eche et al., 1998; Lauterwein et al., 1979; Lee et al., 2013; Lin and Baumgaertner, 2000; Takahashi et al., 2013) . Despite intensive research efforts, the molecular mechanism that underpins melittin activity is still controversial . Melittin-membrane interaction has been shown to depend on peptide concentration, lipid composition, membrane thickness, membrane potential, pH and hydration level (Bradrick et al., 1995; Bradshaw et al., 1994; Dempsey, 1990; Lin and Baumgaertner, 2000) . MD trajectories were used at an early stage to study the interaction of melittin with fully hydrated dimyristoyl phosphatidylcholine (DMPC) bilayer (Bern eche et al., 1998) . This study suggested that the presence of melittin in the upper layer has an effect across both layers of the membrane causing a thinning of the bilayer, allowing water to pass through. Furthermore, it has been reported that at low concentrations, melittin can bind to lipid membranes as a monomer and induce transient leakage, whereas at higher concentrations, it can form stable pores, and at higher concentrations still, melittin can disintegrate the membrane by acting as a detergent (Tosteson and Tosteson, 1981; Ladokhin and White, 2001; Last et al., 2013) . This concentration-dependent phenomenon was originally suggested to be due to the "wedge and edge effect" described by Terwilliger in 1982 (Terwilliger et al., 1982 . However, this model was only based on the structure of melittin and did not consider the lipid bilayer. A recent study now suggests that melittin translocates across the lipid bilayer by transient pore fluctuation, allowing it to form stable pores in the presence of an excess of peptide/lipid ratio .
Trimolecular complexes
The gating-modifier toxins (GMTs) are typically isolated from spider venoms and display an amphipathic surface profile, comprising a hydrophobic patch surrounded by a charged ring, which is similar to melittin and other antimicrobial membranebinding peptides. These toxins alter nerve conduction by interacting with voltage-sensor domains of various ion channels. The first GMT reported binding phospholipids was VsTx1, a toxin isolated from the Chilean rose tarantula (Grammostola spatulata) (Lee and MacKinnon, 2004) . It was reported that there was a 104-fold difference in inhibition of the archaebacterial voltage-dependent potassium channel K V AP once the channel was extracted from the membrane with detergent. Subsequent spin-down and tryptophan fluorescence studies showed that this was most likely due to the peptides ability to partition in membranes, a feature which had not previously reported for this class of peptides (Lee and MacKinnon, 2004) .
Lee and MacKinnon originally reported that VsTx1 access K V AP via the lipid bilayer and binds to both zwitterionic (POPC) and anionic charged (POPE/POPG) phospholipids (Lee and MacKinnon, 2004) . It was later suggested that VsTx1-membrane interaction is dependent on anionic phospholipids (Jung et al., 2005) . MD simulations suggest that VsTx1 preferentially partitions at the water/ membrane interface. Although it does appear that VsTx1 can interact with both zwitterionic and anionic phospholipids, there is a notable difference in how the peptide interacts with the different lipid systems. This difference is most likely brought about by the formation of the electrostatic interactions stabilising the peptide in the membrane, the number of H-bonds able to be formed between the peptide hydrophilic residues and anionic phospholipids headgroups compared to zwitterionic headgroups, as well as the formation of favourable interactions with the hydrophobic core of the bilayer through the hydrophobic residues of VsTx1, which are orientated towards the core of the lipid bilayer (Bemporad et al., 2006) .
Five other GMTs that have been studied for their ability to bind to membranes using MD simulations are HaTx1 (Nishizawa and Nishizawa, 2006) , GsMTx4 (Nishizawa and Nishizawa, 2007) , SGTx1 (Wee et al., 2007) , ProTx-I, Hd1a and ProTx-II . HaTx1 and GsMTx4 have been described as able to enter deeply into lipid bilayers, interacting with the acyl chains of phospholipids and being pulled in by electrostatic forces between the charged residues on the peptide followed by membrane thinning or dimpling Nishizawa, 2007, 2006) . MD simulation studies of other GMTs, including SGTx1, ProTx-I and ProTx-II, show that these peptides have a shallow binding mode, remaining at the water/membrane interface but stabilised by the same electrostatic forces that pulled the peptides deep into the membrane in the Nishizawa studies (Bj€ orklund et al., 2007; Deplazes et al., 2016; Henriques et al., 2016) . Interestingly, the GMT peptides HwTx-IV and Hd1a were evidenced not to bind phospholipid membranes, indicating that membrane interaction is not required for activity (Agwa et al., 2017; Deplazes et al., 2016) . These recent reports are surprising since the GMTs display a remarkably conserved amphipathic surface profile, including several charged Arg and Lys residues as well as a number of Trp residues, known for being involved in membrane-binding event. Therefore, one pressing question in the GMT research field is: why do not all GMTs interact with membrane? However, the rapid advancement in recent years of 3D and 4D NMR and the everincreasing sensitivity of cryo-EM will hopefully allow us to study the molecular interactions driving the trimolecular complex experimentally in great detail.
Venom peptide blockers of voltage-gated ion channels
Voltage-gated sodium and potassium channels are responsible for electrical signalling in the nervous system. Blocking of these ion channels by venom peptides results in rapid paralysis of a prey, making them ideal targets for venomous animals. There is a huge library of venom peptides blocking sodium and potassium channels with high affinity, which may be developed as therapeutics to treat diseases caused by dysfunctional ion channels (Lewis and Garcia, 2003; Wulff et al., 2009 ). The main hurdle in drug design from venom peptides is that they usually lack selectivity for the intended channel subtype, which can cause serious side effects. Engineering analogues that have the desired selectivity is a non-trivial task in the lab as it is mostly based on guess work. Computational modelling of ion channel-peptide complexes could help to solve such design problems by providing an accurate map of the molecular interactions in a complex structure. This, of course, assumes that the crystal structure (or an accurate homology model) of the target ion channel is available (venom peptides being smaller their structures are more easily determined from NMR). Recent reports have shown that accurate protein-peptide complex structures can be obtained by combining docking methods with MD simulations (Alonso et al., 2006; Gordon et al., 2013; Kuyucak and Norton, 2014) . In this scheme, the top binding poses predicted by a docking program are refined in MD simulations until a stable complex structure is obtained. Use of a high-end docking program such as HADDOCK (Dominguez et al., 2003) , which allows ensemble docking and flexibility of the protein/peptide, is imperative to avoid false complex structures and getting poses close to the final structure. This will also ensure faster equilibration during MD simulations, which is computationally much more expensive than docking.
Proper validation of a complex model is essential before the results can be used for drug design purposes. Alanine scanning mutagenesis data provide the best means for testing the accuracy of a predicted binding mode, though mutations of a few critical residues involved in the binding would also be sufficient. If mutation data are not available, one can use the measured binding constant for this purpose by calculating the binding free energy of the peptide from umbrella sampling MD simulations (Chen and Kuyucak, 2011) . It should be stressed that the computation of the binding free energy of peptides from umbrella sampling simulations is not trivial, requiring significant expertise and computational resources as well as the availability of an experimental crystal structure of the target receptor or of a highly homologous receptor (Chen and Kuyucak, 2011; Kuyucak, 2012, 2014; Rashid et al., 2013; Mahdavi and Kuyucak, 2014) . Validated complex structures of a peptide with target and off-target ion channels provide valuable guidance for improving the affinity and selectivity properties of this peptide. Positions that are only important for binding to off-targets but not the target can be mutated to alanine. Similarly, the affinity of a peptide for a target channel can be increased by inspecting its binding mode and mutating those residues on the peptide that could lead to more contacts with the channel residues. Here one can also turn the qualitative predictions gleaned from the binding modes into quantitative ones by performing free energy calculations. The change in the binding free energy due to a mutation can be determined accurately using the free energy perturbation or thermodynamic integration methods . Below we describe a few selected examples of peptide blockers of potassium and sodium channels that illustrate how the proposed methods for modelling work in practice. More comprehensive discussions can be found in recent review articles (Gordon et al., 2013; Kuyucak and Norton, 2014) .
Peptide toxin blockers of potassium channels
The potassium channels were the first voltage-gated ion channels to have their structure determined (Doyle et al., 1998) . The availability of this structural information, which was rare at the time, prompted a great deal of work focusing on peptides that block these channels, and as part of these studies an extensive number of molecular models were generated (Chen and Chung, 2015) . Blockers of K V 1 channels have attracted the most attention because they are linked to several diseases. A prime example is the K V 1.3 subtype, which is a well-established target for the treatment of autoimmune diseases (Chi et al., 2012) . The discovery that ShK toxin from sea anemone binds to K V 1.3 with a picomolar affinity has focused efforts to develop a therapeutic agent from ShK (Chi et al., 2012) . The main hurdle was its lack of selectivity for K V 1.1 in the nervous system. Over 400 ShK analogues were generated to improve selectivity, but the limited success of this endeavour highlights the difficulty of engineering analogues based on purely guess work. Construction of accurate models for the K V 1.1eShK and K V 1.3eShK complexes, which were validated using the available mutation data and binding free energies, provided fresh insights on how to design ShK analogues with improved K V 1.3/K V 1.1 selectivity (Rashid and Kuyucak, 2012) . The success of binding free energy computations on these receptors can be accounted by the availability of an experimental crystal structure of K V 1.2, which is highly homologous to K V 1.3 and K V 1.1. Comparison of the binding modes indicated that some simple mutations, such as K18A and R29A, could improve the selectivity. These have been ignored hitherto because an existing patent on ShK mutations claimed that they reduced the K V 1.3/K V 1.1 selectivity. Binding free energy computations indicated that the K18A mutation would improve the K V 1.3/ K V 1.1 selectivity by more than 2 kcal/mol (~30-fold of K d ) without affecting the affinity for K V 1.3, and this was later confirmed by experiments (Rashid et al., 2013) .
A second example where computational modelling of peptides has played a guiding role is the scorpion toxin HsTx1, which also has a picomolar affinity for K V 1.3 and exhibits some K V 1.3/K V 1.1 selectivity (Regaya et al., 2004) . HsTx1 has a more stable structure than ShK and may offer a better alternative as a therapeutic for autoimmune diseases. Models of K V 1.1eHsTx1 and K V 1.3eHsTx1 complexes (Fig. 2) , validated through comparison of the calculated binding free energies with experiment, have revealed that the R14A mutation could improve the K V 1.3/K V 1.1 selectivity substantially without affecting its affinity for K V 1.3 . This prediction was confirmed in subsequent functional assay experiments, where a selectivity margin of more than 2000-fold in IC 50 was measured for K V 1.3 over K V 1.1 . Thus, HsTx1[R14A] provides the most selective and potent lead so far in the development of therapeutics for autoimmune diseases.
Peptide blockers of sodium channels
Crystal structures of bacterial Na V channels were determined only recently (Payandeh et al., 2011) , and the first eukaryote structure of a Na V channel was determined only this year (Shen et al., 2017) , but there are no structures yet for the mammalian Na V channels. Thus efforts have been focused mainly on constructing accurate homology models for the mammalian Na V channels using the large amount data available on the binding of toxin peptides (Korkosh et al., 2014; Mahdavi and Kuyucak, 2014a) . The pore domain is reasonably well described by these homology models. For example, the model of the complex between Na V 1.4 and m-conotoxin GIIIA provides an accurate representation of the extensive mutation data available for this system (Mahdavi and Kuyucak, 2014a) . This model of the pore of Na V 1.4 was also validated using mutational data of other m-conotoxins (Mahdavi and Kuyucak, 2014b) . The binding mode of GIIIA in the pore is broadly similar to that of toxins interacting with the pore of potassium channels, which is illustrated in Fig. 2 . But problems remain in the modelling of the S5-P1 and P2-S6 linkers in the extracellular turret regions because they differ substantially across the four domains and had until recently no similar counterparts in the Protein Data Bank for homology modelling. The 3.8 Å EM structure of the American cockroach putative Na V channel recently unravelled the structure of these turrets, which are heavily glycosylated, but to our knowledge, this very recent structure has not yet been used in any molecular modelling study of toxins (Shen et al., 2017) . As the pore domains of the Na V 1 subtypes are very similar, accurate modelling of these regions is essential in order to explain the observed variations in the affinities of peptide toxins among the Na V 1 subtypes (Wilson et al., 2011) .
Gating-modifier toxins (GMTs)
GMTs are spider toxins that inhibit the function of a voltagegated channel by binding to the voltage-sensor domain (VSD) (Catterall, 2010) . As already mentioned in Section 2, some of these toxins form a trimolecular complex involving the membrane and a VSD, and in this case the lipid environment and VSD should both be modelled. GMTs typically bind and lock VSDs into a conformation corresponding to the closed channel, but the crystal structures of K V and bacterial Na V channels only display VSDs in conformations associated with the open channel. Several strategies have been used to model the Na V VSDs in a conformational state potentially targeted by the toxins, such as unbiased MD simulations (Jensen et al., 2012) , steered-MD simulations (Tarek and Delemotte, 2013) , metadynamics (Delemotte et al., 2015) or Rosetta modelling (Yarov-Yarovoy et al., 2012) . Accurate modelling of the conformation of the extracellular loops, namely the S1eS2 and especially the S3eS4 segments of the VSDs, is also critical for determining the binding modes of GMTs, but the structure of the bacterial channels are of little help in this regard. The recent EM and X-ray crystallography structures of the cockroach Na V and rabbit Ca V channels (Shen et al., 2017; Wu et al., 2016 Wu et al., , 2015 display VSDs in different activation states and have higher homology of extracellular loops to most mammalian VSDs, offering exciting opportunities to generate more accurate models of the binding mode of GMTs. To our knowledge, the only study reporting the full binding process of a GMT interacting with the membrane was reported by the Sansom group (Wee et al., 2010) . In this study, the interaction between the spider toxin VSTx1, the VSD of K V AP and a POPC bilayer was modelled using coarse-grained MD simulations. The toxin was observed to bind spontaneously to the membrane and diffuse toward the VSD. The coarse-grained model was then used in an all-atom modelling of the binding of VSTx1 with the S3eS4 segment of the VSD. The binding mode of the spider toxin HaTx1 on the K V 2.1 VSD was modelled using a combination of docking using ZDOCK in vacuum and MD simulations in a membrane environment, identifying a unique orientation of HaTx1 compatible with the mutagenesis data (Chen et al., 2012) . Few models featuring interaction of toxins with Na V and Ca V VSDs have been generated so far (Minassian et al., 2013) , but it is expected that recent experimental structures will prompt more extensive modelling studies. An important target from a pharmacological point of view is the sensory Na V 1.7 channel, which plays a key role in inflammatory and neuropathic pain (Vetter et al., 2017) . Computational studies of the binding of selected toxin peptides to the voltage sensor of Na V 1.7 would therefore be very useful in order to characterise their binding modes and design analogues with improved affinity/selectivity profiles for Na V 1.7.
Nicotinic acetylcholine receptors
Nicotinic acetylcholine receptors (nAChRs) are pentameric ligand-gated ion channels that mediate rapid synaptic signal transduction (Taly et al., 2009; Cecchini and Changeux, 2015) and exist as different subtypes depending on subunit composition.
Neuronal subunits include a2e10 and b1e4, while the a, g and d/ε subunits are found in neuromuscular junctions (Gotti et al., 2007) . Each subunit has an extracellular domain (ECD) (a subunits contain a conserved CC motif at the tip of loop C), a transmembrane and an intracellular domain (Unwin, 2005) . The agonist binding site of nAChRs lies between two ECDs of adjacent subunits and is highly conserved within the nAChR family (Brejc et al., 2001) . In this regard, peptide inhibitors have a larger contact surface area with the receptor, with multiple contacting residues that can be modified to modulate selectivity. One such source of nAChR-binding peptides is the family of conotoxins, which are 10e50 residue long disulfiderich peptides isolated from the venoms of marine cone snails (Akondi et al., 2014) . The best-characterised members of this family are a-conotoxins (a-CTXs), which mainly act as antagonists of nAChRs (Lebbe et al., 2014) . Most of these toxins have very similar, rigid structures, displaying a small helical section and two disulfide bonds. They are classified according to the number of residues in the two inter-Cys segments, and most a-CTXs belong to the 3/5, 4/3 and 4/7 subtypes. Due to their selective inhibition of nAChR subtypes, they have therapeutic potential in the treatment of neurological diseases, such as Alzheimer's disease, Parkinson's disease or schizophrenia, or conditions such as neuropathic pain.
a-Conotoxin inhibition of nAChRs: current models and their limitations
Major breakthroughs enabling an understanding of a-CTX/ nAChR interactions have come from crystal structures of the homologous protein AChBP in complex with several different a-CTXs:
ImI (4/3) (Ulens et al., 2006; Hansen et al., 2005) , PnIA variant (4/7) (Celie et al., 2005) , TxIA variant (4/7) (Dutertre et al., 2007) and BuIA (4/4) (Kim and McIntosh, 2012) (PDB: 4ez1) . In all these crystal structures, the a-CTXs have similar binding modes, suggesting that this binding mode should also be conserved for all aCTXs displaying a similar structure (Fig. 3 A and C) . These structures have served as templates for homology modelling of nAChR due to the high sequence similarity between AChBP and the ECD of nAChRs (Sine and Engel, 2006) . MD simulations have been used to refine the structures and examine the motions of many a-CTX/ nAChR complexes built by homology modelling, and these studies have been extensively surveyed elsewhere (Dutertre and Lewis, 2004; Tabassum et al., 2016) . In a recent study, a homology model of a-conotoxin GIC bound to a3b2 nAChR was generated but could not be used to explain all mutational data (Lin et al., 2016) . This model was not refined using MD simulation, which contrast with all studies hereafter cited that produced molecular models with significant explanatory and predictive power. In the current review, we will mention several illustrative studies, and subsequently focus on prospects for novel investigations.
Amongst the first MD simulation studies of a-CTXs was that of the (4/3) RgIA/a9a10 complex (P erez et al., 2009) , where RgIA-R7 was found to form multiple contacts with a9-D198 and -P197. A recent MD study of the same complex (Azam et al., 2015) combined with electrophysiological recording of receptor mutants revealed that the interface between the a10 and a9 subunits is the likely target of RgIA. As an example of a study of 4/7 a-CTXs, MD simulations of the AuIB/a3b4 complex identified AuIB-F9 as a key residue to its inhibitory activity, this residue being "sandwiched" between b4-W59 and -K61 (Grishin et al., 2013) . Alanine substitutions of these two residues in the receptor resulted in dramatic loss of inhibition, confirming that they play a crucial role at the interface. Molecular models of the interaction between conotoxins and nAChRs provided qualitative insight of important pairwise interactions, but the low resolution of such models prevented the quantitative predictions of absolute binding affinities, for example using umbrella sampling. Nevertheless, several studies have used mutational energy prediction to support the validity of computational models . For example, Yu and colleagues used a combination of molecular mechanics (MM) simulations and Poisson-Boltzmann/Surface Area (PBSA) free energy (DG) calculations to estimate the mutational free energies of a range of ImI mutants bound to the homopentameric a7 nAChR (Yu et al., 2011) . Mutational data for Vc1.1 inhibition of the a9a10 nAChR have also been rationalised using MM-PBSA, and this method was employed to discover the binding mode and design more potent mutants (Yu et al., 2013) . Protein surface topography is a recently developed visualisation tool that represents on a map of the average properties of the interactions between a-conotoxins and nAChR binding sites recorded during an MD simulation . This method was used to design more potent and selective a-conotoxin PnIA analogues targeting the a7 and nAChR.
MD simulations have also been applied to explain speciesdependant differences in nAChR response to a-CTXs, motivated by the potential development of conotoxins as therapeutics. Although nAChR orthologues have a high degree of sequence identity, markedly different responses to some a-CTXs have been reported between species. A recent study of the activity of RegIIA showed that it potently inhibits rat, but not human, a3b2 (Kompella et al., 2015a) , with the sole species-determining residue being b2-Q198 (rat) compared with b2-P198 (human). This position 198 is not in direct contact with RegIIA in the binding mode derived from the AChBP-PnIA variant structural template. However, MM-PBSA calculations suggest that the amino acid at position 198 of the b2 subunit indirectly influences the interaction between RegIIA-N11/ N12 and a3-E195. The N11 and N12 residues of RegIIA were shown to be crucial for RegIIA activity, with their Ala mutants exhibiting greater selectivity for a3b4 over a3b2 (Kompella et al., 2015b) .
Chemical modifications of a-CTX have been employed to impart receptor selectivity. Studies of chemically-modified a-CTX demonstrated that dicarba-Vc1.1 and RgIA are active at either nAChR (ion channel) or GABA B receptor (G-protein coupled receptor, GPCR) depending on the position of disulfide substitution, thus causing a switch in selectivity between two entirely different classes of receptors. MD simulations of the native and dicarba-modified Vc1.1 and RgIA bound to the ECD of a9a10 suggested that dicarba substitution at positions 2 and 8 of the conotoxins results in loss of contacts of these residues with the cystine sulfurs at the tip of loop C. The disruption in conotoxin-receptor contact at these positions may be partly responsible for the loss of activity of the 2,8-dicarba conotoxins at nAChR.
The presently-available AChBP/CTX complex structures display a similar binding mode in the orthosteric binding site, but the development of selective inhibitors of certain nAChR subtypes might require targeting other binding sites. This is starkly illustrated by the a4b2 nAChR subtype, for which there is presently no known potent (let alone specific) conotoxin inhibitor, despite efforts at designing one based, for example, on a-conotoxin GID (Banerjee et al., 2014) . A study of TxIA interaction with a4b2 showed that differential activity between the a3b2 and a4b2 subtypes can be attributed to the occlusion of the agonist binding site by a4-R185 and a4-P195 (Beissner et al., 2012) . Thus, the shape of the a4b2 subtype illustrates a potentially insurmountable obstacle to a-CTXs inhibition, precluding design of novel toxins targeting its orthosteric site. The a5 subunit also has R185 and P195 residues, and could similarly be difficult to target by a-CTXs. Engineering or discovering conotoxins able to inhibit nAChRs by interacting with an allosteric binding site would offer potential alternatives to design inhibitors of a4b2 or a5-containing nAChR subtypes.
Beyond the classical binding site: prospects from new conotoxins and nAChR structures
Potential allosteric binding sites can be identified using MD simulations of a-CTX unbinding from the orthosteric binding site of nAChRs . The computation of the potential of mean force using the Jarzynski equation was used to identify sites of potential interest in the unbinding pathway of a-conotoxin ImI from the a7 nAChR (Yu et al., 2012) . A more accurate but computationally intensive method to compute the potential of mean force is umbrella sampling, in which several simulations are carried out with the ligand restrained at different distances from the initial binding site (Woo and Roux, 2005) . This approach has been used to study the unbinding of ImI and PnIA from AChBP as well as GID unbinding from a4b2 and a7 nAChRs (Suresh and Hung, 2016) . The increased computational power only recently enabled such tedious computations because the conformational landscape of the relative flexible C-loop needs to be modelled during the unbinding process from this large receptor. Although a number of sites along the unbinding pathways have been identified in these studies, their potential as allosteric inhibitory binding sites is presently speculative. A more promising avenue is the recent discovery of a novel dimeric nAChR-inhibiting aD-conotoxin, GeXXA (S. , which can inhibit nAChRs non-competitively. Each chain includes a C-terminal domain (CTD, residues 21e50) which, in monomeric form, retains inhibitory activity against a9a10 nAChR. Dimeric aD-GeXXA exhibited a stronger preference for rat a9a10 compared to the human subtype, with rat a10-H7 (L7 in human) determining the toxin's species preference. Position 7 was therefore proposed to be part of the binding site of aD-GeXXA. The binding mode was suggested to involve cooperative binding of aD-GeXXA to the ECD a-helices, spanning two inter-subunit interfaces (Fig. 3 B and D) . Although the GeXXA residues responsible for its activity have yet to be identified, they are likely to be in the CTD, since the monomeric GeXXA CTD peptide (comprising residues 21e50 only) was shown to have nAChRinhibitory activity. We further propose a speculative model, shown in Fig. 3 , in which rat a10-H7 is in contact with two GeXXA-D33 residues, the latter being the only acidic residue in GeXXA and therefore most likely to contribute to electrostatic interactions between the toxin and the crucial H7 of rat a9a10. Such a (potentially) strong interaction would be lacking in human a9a10, and might explain the lower potency of GeXXA against the human subtype. Another a-CTX called GeXIVA was recently discovered to non-competitively inhibit nAChRs, and MD simulations suggested a binding site located on the a-helices of the ECD, similarly to aDGeXXA (Luo et al., 2015) . This novel interaction mechanism opens up new opportunities for the rational design of toxins which target nAChRs, an approach especially valuable for those subtypes which have proved resistant to competitive antagonism by a-conotoxins.
Another major breakthrough in understanding neuronal nAChRs is the recent publication of the crystal structures of the a2 (Kouvatsos et al., 2016) and a4b2 (Morales-Perez et al., 2016) nAChRs. These are the first neuronal nAChR structures to be solved in pentameric form, and both were crystallised in the classical "open-like" ECD conformation in which loop C is enclosed around the agonist. The folds of the ECDs were found to be broadly similar to that of AChBP. For a4b2, the crystal structure sheds light on side chain conformations at the agonist binding a(þ)b(À) and nonbinding b(þ)a(À) interfaces which explain the inability of the latter to bind acetylcholine and other agonists. In the context of inhibitor design, the a4b2 channel structure is in a desensitised, non-conducting state, which raises the possibility of using this structure to aid the design of a-CTXs which can trap the nAChR in a desensitised state in the absence of agonists, rather than directly targeting the resting state structure as in conventional antagonists. Receptor desensitisation is readily achieved by prolonged exposure to agonist; however, cotinine (a choline metabolite) and novel choline analogues have been shown to desensitise nAChRs without a preceding agonist action (Buccafusco et al., 2009) . These "silent desensitisers" were proposed to act allosterically. Lastly, the availability of the a2 and a4b2 agonist-bound structures may open up opportunities for improved rational design of CTX positive allosteric modulators. Although conotoxins mainly act as inhibitors, the 4/7 a-CTXs SrIA, SrIB and EI showed potentiation of a4b2 if briefly applied at low concentrations (L opez-Vera et al., 2007) . The newlyavailable structures of the agonist-bound a2 and a4b2 receptors, coupled with advances in molecular modelling and simulation techniques, can serve to greatly enhance our understanding of the intriguing potentiation mechanism of these conotoxins, and perhaps lead to the design of analogues with markedly improved selectivity as positive modulators.
Other targets
Besides voltage-gated ion channels and nAChRs, animal toxins also modulate the activity of a range of membrane proteins, and a selection of these targets are highlighted in this section. The ASIC channels are ion channels activated by pH. Several crystal structures of ASICs in complex with the spider toxin PcTx1 (psalmotoxin 1) or the snake toxin MiTX have been determined, where the toxins were used to stabilise the channels into open states (Baconguis et al., 2014; Baconguis and Gouaux, 2012; Dawson et al., 2012) . The binding sites of both toxins overlap and are located at the interface between adjacent subunits. A hydrophobic patch and a cluster of charge interactions were initially hypothesised as essential for PcTx1 binding at the interface between adjacent subunits (Fig. 1) . MD simulations of the PcTx1/ASIC1a complex revealed that 31 molecular interactions at the interface were potentially stable, narrowing down the number of the residues to study by mutagenesis, resulting in the identification of only six essential PcTX1 positions (Saez et al., 2015) . The binding mode of snake toxins mambalgin-1 and -2 to ASIC1 were studied by rigid body docking oriented by results of double-mutant cycle analysis (Mourier et al., 2016) or substitutions of the channel for the amino acid of corresponding residues of ASIC2a (Salinas et al., 2014) . Considerable overlap of binding modes of the mambalgin peptides with that of PxTx1 was suggested from the models.
GABA A is a Cys-loop ligand-gated ion channel, similarly to nAChRs, and it is the target of benzodiazepine and several anaesthetics. It was recently discovered that a-conotoxin ImI and bungarotoxin, which inhibits nAChRs, were also active at GABA A (Kudryavtsev et al., 2015) . A model of the interaction between ImI and GABA A a1b3 was generated by homology with the crystal structures of GABA A (Miller and Aricescu, 2014) as well as of ImI/ AChBP complex (Hansen et al., 2005) . This model was refined by 100 ns MD simulation in implicit solvent, revealing a similar binding of ImI in the GABA A binding site as in that of AChBP (Kudryavtsev et al., 2015) .
GPCRs, or seven-transmembrane-helix receptors, transduce various type of signal received extracellularly and this large class of receptors is the most successful drug target. For example the a1-adrenoreceptors activation causes vasoconstriction and its inhibitors can be used to treat hypertension. The conotoxin TIA is a negative allosteric modulator of this GPCR (Sharpe et al., 2003 ) and a molecular model of its interaction with a human subtype was built (Ragnarsson et al., 2013) . This model was generated by HADDOCK (Dominguez et al., 2003 ) using a homology model of the human a1B-adrenoreceptor and mutants built by homology with the crystal structure of the turkey b 1 -adrenoreceptor (Warne et al., 2008) . The molecular models helped identify a crucial salt bridge and cationep interactions at the interface, both involving TIA Arg-4.
The muscarinic acetylcholine receptors are the second major class of receptors activated by acetylcholine at the synapse beside the nAChRs. They are linked to Alzheimer's disease, schizophrenia and chronic obstructive pulmonary disease and exist as five subtypes M1eM5. Four crystal structures of these receptors have been published: the rat M3 subtype (Kruse et al., 2012) , the human M2 subtype (Kruse et al., 2013) and recently the human M1 and M4 subtypes were reported (Thal et al., 2016) . Some snake three-finger toxins are subtype-selective allosteric modulators of the muscarinic receptors. A model of the interaction of the green mamba muscarinic toxins MT7, which is subtype-selective for the M1 receptor, was created by docking the NMR solution structure of MT7 with homology models of human muscarinic receptors using patchdock and firedock (J. . Mutational energies were carried out using the MM-GBSA energy function applied to 1000 snapshots extracted from a 20 ns MD simulation, resulting in a reasonable correlation between the predicted energies and experimental activity. The decomposition of energy terms per residues was used to identify residue hotspots, which were supported by published mutational data. The interactions of the "weak" toxin WT from the snake Naja kaouthia were docked on the human M1 and M3 subtypes using Rosetta and ZDOCK . The stability of the complex observed during a 200 ns simulation carried out in a lipid membrane correlated with activity.
Conclusion and outlook
In this review, we have described using a range of examples how molecular modelling has been used as a guide in studies of animal venom toxins interacting with cell membranes and membrane receptors. Regarding membrane interaction, molecular dynamics simulations of spider GMTs helped study their partition in membranes as well as build hypotheses on the mechanism of membrane poration by the bee toxin melittin. The vast majority of molecular models of the binding mode of toxins with membrane receptors focused on providing a rationale to mutagenesis data. In some instance, the models were in turn used to suggest modification to the toxins to improve affinity or selectivity, for example for the anemone toxin ShK (Rashid et al., 2013) , the cone snail toxin Vc1.1 (Yu et al., 2013) or the scorpion toxin HsTx1 . Molecular models also helped designing toxins with improved stability, which is required for potential medical or biotechnological applications, and at the same time retain a biological activity. To this regard we cited attempts at replacing the disulfide bonds of cone snail toxins RgIA and Vc1.1 Yu et al., 2015) .
The research landscape focusing on animal peptides toxins active at membrane proteins is rapidly changing because of the increasing pace at which high-resolution structures of these proteins are discovered, mainly due to the advent of improved EM techniques. This is an exciting time for the study of animal toxin structure-activity relationship studies, as these new structures can be used to generate highly accurate models of the interactions of these peptides. The recent experimental structures of eukaryote voltage-gated ion channels, ie rabbit Ca V 1.1 and cockroach Na V , will especially benefit the modelling of pore-blocker toxins because these new structures give information on the so-called P-loops, which are large loops hovering over the entrance of the pore of the channel with a structure which could not be hitherto predicted. The crystal structure of the a4b2 nAChR provides atomic resolution details of the orthosteric binding site, which is targeted by numerous spider, cone snail, and snake toxins and which was typically modelled by homology with distant invertebrate homologues. It should be nevertheless noted that the activation state in which the nAChR, Ca V and Na V have been captured is not directly relevant to the modelling of all toxins, and that experimental structures of an nAChR in closed state or a Na V /Ca V in active state would help build even more accurate models of the binding mode of toxins, which are central to structure-activity relationships studies.
Interestingly, the experimental structures of the molecular targets of certain class of toxins have been determined but to our knowledge no binding mode was yet proposed; for example for the cone snail conantokins, which inhibit the NMDA receptor (Karakas and Furukawa, 2014; Lee et al., 2014) , or for the scorpion maurocalcin, which inhibits the ryanodine receptor (Zalk et al., 2015) . The increased accuracy of molecular models enables more reliable estimates of binding energies. Increasing computational power enables increasing conformational exploration and therefore increased accuracy of predicted energies. The computation of energy have been used to support binding modes proposed in molecular models as well as to rationalise mutations studies, but the major challenge remains the prediction of toxins selectivity. Most toxins act on protein targets that exist as multiple closely-related subtypes, and determining the activity at a large number of subtypes is experimentally challenging. The development of computational methods to predict the selectivity of toxins between target subtypes would constitute a major breakthrough for toxin research.
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